Drug General Information
Drug ID
D08QHX
Former ID
DCL001223
Drug Name
PRX00933
Indication Obesity; Diabetes [ICD9: 250, 278; ICD10:E08-E13, E66] Phase 2 [551552]
Company
Proximagen Group plc
Target and Pathway
Target(s) 5-hydroxytryptamine 2C receptor Target Info Agonist [551552]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 5515522011 Pipeline of Proximagen Group plc.
Ref 5515522011 Pipeline of Proximagen Group plc.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.